Evaluating a new treatment for hemorrhoids using artery embolization
Official title: A Randomized Comparative Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease
Run by Universitair Ziekenhuis Brussel · NCT05697562 · Data updated 2026-11-12
This study is testing a new, less invasive treatment for hemorrhoids called artery embolization to see if it works as well as current methods for reducing bleeding and symptoms in adults with hemorrhoids.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Universitair Ziekenhuis Brussel Academic / other |
| Drugs / interventions | Radiation |
| Locations | 1 site (Jette) |
| Status | Recruiting |
| Started | June 1, 2023 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2030 |
| Registry record updated | December 18, 2025 |
| Trial ID | NCT05697562 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with grades I-III hemorrhoids experiencing significant rectal bleeding.
✕Probably not a fit
Patients with permanent hemorrhoidal prolapse, rectal prolapse, or a history of proctological surgery for hemorrhoids may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness and safety of Superior Rectal Artery Embolization (SRAE) as a minimally invasive treatment for hemorrhoidal disease (HD) characterized by significant rectal bleeding. The study aims to compare SRAE with established treatments like Rubber Band Ligation (RBL) and Doppler-Guided Hemorrhoidal Artery Ligation (DG-HAL) to determine if SRAE is equally effective in controlling symptoms and bleeding. Participants will include adults with grades I-III hemorrhoids, and the trial will assess the feasibility of SRAE while ensuring no damage to the sphincter or mucosal tissue occurs. The results will help define the therapeutic role of SRAE in managing HD.
Why it matters
Potential benefit: If successful, this treatment could provide a safer and less invasive option for patients suffering from hemorrhoidal disease.
How similar studies have gone: Previous studies have shown promising results for SRAE, but this trial aims to confirm its efficacy in a randomized controlled setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients referred for Hemorrhoidal disease with bleeding are eligible. Significant bleeding is defined as a HBS of ≥ 5. * Age \> 18 years old; * Sexes eligible for study: all * Hemorrhoidal disease grade I-III according the Goligher classification with rectal bleeding as predominant symptom * History of prior instrumental treatment of HD does not prohibit inclusion * Able to understand and read Dutch, French or English Exclusion Criteria: * Permanent hemorrhoidal prolapse/grade IV hemorrhoidal disease * Rectal prolapse * History of proctological surgery for HD * Acute complicated course of HD i.e. acute thrombosis (fluxio hemorrhoidalis or perianal hematoma) * Anal stenosis, congenital of acquired * Chronic anal fissure * Active rectal inflammation, including peri-anal abscess (e.g. Inflammatory Bowel Disease, infectious,…) * History of colorectal or anal cancer * History of rectal or sigmoidal resection * Portal hypertension and liver cirrhosis Child Pugh C * Radiation rectitis * Neurological disease involving anal sphincter musculature * Severe psychiatric disorder * Pregnancy * Allergy to iodinated contrast agents * Colorectal neoplasia as the cause of bleeding (excluded with a (virtual) colonoscopy in the last year)
Where it's running
-
UZ Brussel
Jette, Belgium Recruiting
Study contacts
- Study coordinator: Magali Surmont
- Email: magali.surmont@uzbrussel.be
- Phone: +32 2 477
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ligasure vs. Conventional Diathermy in Hemorrhoidectomy
This study tests whether using the Ligasure device during hemorrhoidectomy reduces pain and bleeding compared with conventional diathermy in patients with symptomatic hemorrhoids.
-
Sutureless hemorrhoidectomy vs conventional ligation for advanced hemorrhoids
This study tests whether a sutureless, energy-based hemorrhoidectomy can reduce pain and recovery time compared with the standard Milligan-Morgans procedure in adults with Grade III–IV hemorrhoids.
-
Botulinum toxin A injection before hemorrhoid surgery to reduce postoperative pain
This study will see if injecting botulinum toxin A into the internal anal sphincter a week before hemorrhoidectomy reduces post-operative pain for adults with grade III–IV hemorrhoids.
-
Pudendal nerve block versus sacral erector spinae (ESP) block for pain after hemorrhoidectomy
This will test whether the sacral erector spinae (ESP) block gives equal or better pain relief than the pudendal nerve block for adults having elective hemorrhoid surgery.
-
Are hemorrhoids linked to varicose veins in the legs?
This project will see if adults with hemorrhoids are more likely to have varicose veins in their lower limbs by comparing 200 people with hemorrhoids to 200 patients with other benign anorectal conditions.
-
Ultrasound-guided sacral erector spinae plane block versus saddle block for anesthesia during hemorrhoidectomy
This will test whether an ultrasound-guided sacral erector spinae plane block works as well as a saddle block for adults having hemorrhoidectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.